Source link : https://newshealth.biz/health-news/fda-warns-of-new-blood-cancers-with-sarcoma-lymphoma-drug/
The FDA on Monday alerted clinicians about the risk of new primary hematologic malignancies in patients treated with tazemetostat (Tazverik), a sarcoma and lymphoma drug now being pulled from global markets. The risk was known when the EZH2 inhibitor was granted accelerated approvals in 2020, with an incidence of 1.7%. But new data from the […]
The post FDA Warns of New Blood Cancers With Sarcoma, Lymphoma Drug first appeared on News Health.
—-
Author : News Health
Publish date : 2026-05-12 16:07:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8